MUSK and myasthenia gravis: In 2018, Morsch et al., using a mouse model of myasthenia gravis generated via daily injections of IgG from an anti-MuSK-positive MG patient, demonstrated for the first time that acute treatment with WIN 55212 is beneficial for rescuing disease-impaired neuromuscular transmission [98].